By ISOPP Research Committee Chair on 19th September 2025

ISOPP International Symposium 2026 is now open for abstract submissions

I’m excited to share that the ISOPP International Symposium 2026 is now open for abstract submissions! This 24-hour virtual event takes place on March 20, 2026, and will bring together…

Read article
By Research committee on 19th September 2025

Invite to take part in a survey as part of the SWITCH study

We are inviting healthcare professionals to take part in a short survey as part of the SWITCH study, a research project funded by the National Institute for Health and Care…

Read article
By BOPA Research subcommittee on 14th September 2025

Survey: Fertility and the use of Immune Checkpoint Inhibitor Therapy (Survey from Royal Marsden Hospital)

Immune checkpoint inhibitors, such as atezolizumab, nivolumab and pembrolizumab have transformed the treatment landscape for many cancers. Cancers such as melanoma and Lynch-syndrome related tumours necessitating immune checkpoint inhibitors are…

Read article
By Clayton Wong on 8th September 2025

Opening soon: Abstract submission for the ISOPP International Symposium 2026  

Are you working on an innovative oncology pharmacy project, service evaluation, or research study? Here’s your chance to share it with a global audience! Submit your abstract(s) online by Friday,…

Read article
By Clayton Wong on 23rd August 2025

Upcoming Webinar Series: Systematic Reviews & Covidence – Register Now!

BOPA is pleased to announce a new 3-part webinar series, delivered in collaboration with Covidence, to support members in understanding and engaging with systematic reviews in oncology pharmacy.   This…

Read article
By BOPA Research committee on 26th June 2025

SURVEY deadline extended – The use and development of ChemoCare Electronic Prescribing System for systemic anti-cancer therapy

Dear Oncology/Haematology Pharmacist, You are invited to participate in a survey exploring the factors that influence UK-registered pharmacists’ use and the development of ChemoCare Electronic Prescribing system (EPS) for systemic…

Read article
By BOPA Research committee on 18th June 2025

Share Your Insights – The use and development of ChemoCare Electronic Prescribing System for systemic anti-cancer therapy

Dear Oncology/Haematology Pharmacist, You are invited to participate in a survey exploring the factors that influence UK-registered pharmacists’ use and the development of ChemoCare Electronic Prescribing system (EPS) for systemic…

Read article
By BOPA Research Committee on 8th June 2025

Calling all cancer service pharmacy managers to complete this survey!

BOPA and SOPPG (Scottish Oncology Pharmacy Practice Group) are collaborating to validate and hopefully publish an oncology pharmacy workforce tool.  We need the tool to be trialled to validate and…

Read article
By BOPA research subcommittee on 4th June 2025

Celebration of BOPA member’s recent publications (June 2025)

We are delighted to share that so many of our members have had manuscripts published recently. Here are some that we are aware of but if there are others then…

Read article
By BOPA research subcommittee on 2nd June 2025

27th Annual BOPA Conference October 2024 – Abstracts now published

Congratulations to all abstract authors at the 27th Annual BOPA Conference 11-13 October 2024. The abstracts have been published in the Journal of Oncology Pharmacy Practice and can be found…

Read article
By BOPA Committee on 3rd May 2025

Let’s Talk About SACT podcast has been featured in the TOP 40 pharmacology Podcasts worldwide

The BOPA podcast team (Michal Sladkowski, Chiara Creed and Eleanor Meerstadt) are thrilled to share that the Let’s Talk About SACT podcast has been featured in the TOP 40 pharmacology…

Read article
By BOPA Research Committee on 27th April 2025

SURVEY: Understanding Clinicians’ perceptions of a Decision Support tool for Lung Cancer Treatment

Dear BOPA member, Tarini Deleep and Dr Pinkie Chambers from University College London are developing a risk prediction model to help identify patients with incurable Non Small Cell Lung Cancer,…

Read article